Determining Airway pH by Compartmental Exhaled Nitric Oxide Levels During Alkaline Buffer Challenge

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT04738422
Phase
PHASE2
Status
Enrolling By Invitation

Conditions

  • Airway Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - 60 Years
Healthy Volunteers
Accepted

Interventions

  • Alkaline glycine — DRUG
    Subjects will inhale alkaline glycine via nebulizer. Alkaline glycine is an alkaline medication designed for medication.

Study Details

Airway pH imbalances cause numerous adverse physiological changes within the airways, including hyperreactivity, cough, bronchoconstriction, ciliopathy, decreased response to bronchodilators, bacterial growth, nitrosative/oxidative stress, neutrophilic/eosinophilic inflammation, and cell death. Airway pH is known to be low (acidic) in chronic and acute pulmonary diseases. The gold standard approach to measuring airway pH is to bronchscopically obtain epithelial cell lining fluid using protected brush sampling. The expense and invasive nature of this approach is a barrier to fully characterizing the role of airway pH in the health and disease. In this study, we will evaluate non-invasive clinical methods that can be done using equipment standard in clinical pulmonary function laboratories for measuring airway pH.

Key Dates

Start date
Sep 11, 2020
Status verified
Dec 2025
Primary completion
Jul 15, 2028
Completion
Jul 15, 2028

Study Design

Enrollment
150 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Alkaline glycine Inhalation
    Subjects inhale alkaline glycine

Primary Outcome Measure

Compartmental FeNO [ Time Frame: Study is a single visit, lasting less than two hours ]

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana University School of MedicineIndianapolisIndiana46219-

Find similar trials in Indianapolis, IN

Related Studies